COMMUNIQUÉS West-GlobeNewswire
-
NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US
22/03/2024 - 07:00 -
Communiqué de presse : Mise en ligne du document «Q1 2024 Memorandum for modelling purposes»
22/03/2024 - 07:30 -
Press Release: Availability of the Q1 2024 Memorandum for modelling purposes
22/03/2024 - 07:30 -
Nicox - Lettre aux Actionnaires
22/03/2024 - 07:30 -
Nicox's Shareholder Letter
22/03/2024 - 07:30 -
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
22/03/2024 - 00:49 -
Theratechnologies nomme Jordan Zwick à son conseil d’administration
22/03/2024 - 01:00 -
Theratechnologies Appoints Jordan Zwick to its Board of Directors
22/03/2024 - 01:00 -
HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
22/03/2024 - 01:00 -
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
22/03/2024 - 02:40 -
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
21/03/2024 - 21:01 -
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results
21/03/2024 - 21:01 -
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
21/03/2024 - 21:01 -
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
21/03/2024 - 21:01 -
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
21/03/2024 - 21:02 -
Americans with Disabilities Act (ADA) May Protect Physicians Wrongfully Compelled to Have Psychiatric Evaluation, according to Journal of American Physicians and Surgeons
21/03/2024 - 21:03 -
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
21/03/2024 - 21:05 -
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
21/03/2024 - 21:05 -
ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
21/03/2024 - 21:05
Pages